Unlock stock picks and a broker-level newsfeed that powers Wall Street.

NasdaqGS - Delayed Quote USD

Gossamer Bio, Inc. (GOSS)

1.0950
+0.0050
+(0.46%)
At close: May 7 at 4:00:00 PM EDT
1.0900
-0.00
(-0.46%)
After hours: May 7 at 5:39:12 PM EDT
Advanced Chart
Loading Chart for GOSS
  • Previous Close 1.0900
  • Open 1.0900
  • Bid 1.0700 x 300
  • Ask 1.1200 x 300
  • Day's Range 1.0600 - 1.1300
  • 52 Week Range 0.4990 - 1.5500
  • Volume 743,010
  • Avg. Volume 1,733,973
  • Market Cap (intraday) 248.807M
  • Beta (5Y Monthly) 1.82
  • PE Ratio (TTM) --
  • EPS (TTM) -0.2500
  • Earnings Date May 7, 2025 - May 9, 2025
  • Forward Dividend & Yield --
  • Ex-Dividend Date --
  • 1y Target Est 7.46

Gossamer Bio, Inc., a clinical-stage biopharmaceutical company, focuses on developing and commercializing seralutinib for the treatment of pulmonary arterial hypertension (PAH) in the United States. The company is developing GB002, an inhaled, small molecule, platelet-derived growth factor receptor, or PDGFR, colony-stimulatin factor 1 receptor and c-KIT inhibitor, which is in Phase 3 clinical trial for the treatment of PAH. It has license agreements with Pulmokine, Inc. to develop and commercialize GB002 and related backup compounds. The company was formerly known as FSG, Bio, Inc. and changed its name to Gossamer Bio, Inc. in 2017. The company was incorporated in 2015 and is headquartered in San Diego, California.

www.gossamerbio.com

144

Full Time Employees

December 31

Fiscal Year Ends

Healthcare

Sector

Biotechnology

Industry

More about Gossamer Bio, Inc.

Recent News: GOSS

View More
View More

Performance Overview: GOSS

Trailing total returns as of 5/7/2025, which may include dividends or other distributions. Benchmark is S&P 500 (^GSPC) .

YTD Return

GOSS
20.99%
S&P 500 (^GSPC)
4.26%

1-Year Return

GOSS
49.59%
S&P 500 (^GSPC)
8.55%

3-Year Return

GOSS
84.13%
S&P 500 (^GSPC)
36.57%

5-Year Return

GOSS
92.35%
S&P 500 (^GSPC)
95.45%

Compare To: GOSS

Compare

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

GOSS
Gossamer Bio, Inc.
1.0950
+0.46%
Mkt Cap 248.807M
Industry Biotechnology
HOOK
HOOKIPA Pharma Inc.
1.6100
+8.78%
Mkt Cap 19.614M
Industry Biotechnology
ALEC
Alector, Inc.
1.0200
-2.86%
Mkt Cap 101.992M
Industry Biotechnology
STOK
Stoke Therapeutics, Inc.
8.66
-1.03%
Mkt Cap 472.809M
Industry Biotechnology
BDTX
Black Diamond Therapeutics, Inc.
1.5500
+5.80%
Mkt Cap 87.849M
Industry Biotechnology
NUVB
Nuvation Bio Inc.
2.0400
-2.39%
Mkt Cap 692.925M
Industry Biotechnology
INZY
Inozyme Pharma, Inc.
1.3300
+5.56%
Mkt Cap 85.867M
Industry Biotechnology
STRO
Sutro Biopharma, Inc.
0.9934
+4.56%
Mkt Cap 83.222M
Industry Biotechnology
PASG
Passage Bio, Inc.
0.3425
+1.30%
Mkt Cap 21.286M
Industry Biotechnology
MRSN
Mersana Therapeutics, Inc.
0.3245
+2.43%
Mkt Cap 40.443M
Industry Biotechnology
SGMO
Sangamo Therapeutics, Inc.
0.6504
+6.27%
Mkt Cap 149.067M
Industry Biotechnology

Statistics: GOSS

View More

Valuation Measures

Annual
As of 5/6/2025

  • Market Cap

    247.67M

  • Enterprise Value

    156.04M

  • Trailing P/E

    --

  • Forward P/E

    --

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    2.15

  • Price/Book (mrq)

    8.40

  • Enterprise Value/Revenue

    1.36

  • Enterprise Value/EBITDA

    --

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    -49.28%

  • Return on Assets (ttm)

    -11.94%

  • Return on Equity (ttm)

    -122.54%

  • Revenue (ttm)

    114.7M

  • Net Income Avi to Common (ttm)

    -56.53M

  • Diluted EPS (ttm)

    -0.2500

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    294.52M

  • Total Debt/Equity (mrq)

    687.92%

  • Levered Free Cash Flow (ttm)

    -16.7M

View More

Research Analysis: GOSS

View More

Earnings Per Share

Consensus EPS
 

Revenue vs. Earnings

Revenue 9.38M
Earnings -33.03M

Q1'24

Q2'24

Q3'24

Q4'24

0
50M
 

Analyst Recommendations

  • Strong Buy
  • Buy
  • Hold
  • Underperform
  • Sell
 

Analyst Price Targets

1.25
7.46 Average
1.0950 Current
15.00 High
 
View More

People Also Watch

ALEC Alector, Inc.
1.0200
-2.86%
 
STOK Stoke Therapeutics, Inc.
8.66
-1.03%
 
BDTX Black Diamond Therapeutics, Inc.
1.5500
+5.80%
 
DTIL Precision BioSciences, Inc.
5.18
+1.57%
 
AKRO Akero Therapeutics, Inc.
42.79
+1.83%
 
KLDO Kaleido Biosciences, Inc.
0.0001
0.00%
 
PASG Passage Bio, Inc.
0.3425
+1.30%
 
HOOK HOOKIPA Pharma Inc.
1.6100
+8.78%
 
CABA Cabaletta Bio, Inc.
1.1600
+0.87%
 
RVMD Revolution Medicines, Inc.
37.66
+0.59%
 
SPRO Spero Therapeutics, Inc.
0.5780
-2.03%
 
KZR Kezar Life Sciences, Inc.
4.0800
-1.92%
 
NKTX Nkarta, Inc.
1.8700
+0.54%
 
PLRX Pliant Therapeutics, Inc.
1.4300
0.00%
 
ANAB AnaptysBio, Inc.
19.68
-2.19%
 
ALLO Allogene Therapeutics, Inc.
1.2000
-6.25%